Cover Image

Increase in soluble CD95L during subacute phases after human spinal cord injury: a potential therapeutic target

A pilot study measuring the levels of serum-soluble CD95 ligand (CD95L) in eight spinal cord-injured patients.

Saved in:
Bibliographic Details
Main Authors: Biglari, Bahram (Author) , Büchler, Axel (Author) , Swing, Tyler (Author) , Biehl, E. (Author) , Roth, H. J. (Author) , Bruckner, Thomas (Author) , Schmidmaier, Gerhard (Author) , Ferbert, Thomas (Author) , Gerner, Hans-Jürgen (Author) , Moghaddam-Alvandi, Arash (Author)
Format: Article (Journal)
Language:English
Published: 2013
In: Spinal cord
Year: 2013, Volume: 51, Issue: 3, Pages: 183-187
ISSN:1476-5624
DOI:10.1038/sc.2012.139
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/sc.2012.139
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/sc2012139
Get full text
Author Notes:B. Biglari, A. Büchler, T. Swing, E. Biehl, H.J. Roth, T. Bruckner, G. Schmidmaier, T. Ferbert, H.J. Gerner and A. Moghaddam
Description
Summary:A pilot study measuring the levels of serum-soluble CD95 ligand (CD95L) in eight spinal cord-injured patients.
Item Description:published online 27 November 2012
Gesehen am 25.11.2020
Physical Description:Online Resource
ISSN:1476-5624
DOI:10.1038/sc.2012.139

Similar Items